Zhuping Xu

579 total citations
35 papers, 384 citations indexed

About

Zhuping Xu is a scholar working on Molecular Biology, Ophthalmology and Immunology. According to data from OpenAlex, Zhuping Xu has authored 35 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Ophthalmology and 6 papers in Immunology. Recurrent topics in Zhuping Xu's work include Ocular Diseases and Behçet’s Syndrome (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Corneal Surgery and Treatments (3 papers). Zhuping Xu is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Corneal Surgery and Treatments (3 papers). Zhuping Xu collaborates with scholars based in China, Australia and United Kingdom. Zhuping Xu's co-authors include Hui Jiang, Qin He, David J. Pintel, Zhenyu Duan, Dongsheng Duan, Qiyong Gong, Yi Lai, Jianming Qiu, Chaoyang Ye and Yongping Yue and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Zhuping Xu

31 papers receiving 380 citations

Peers

Zhuping Xu
Xuemin Li China
Sibtain Afzal Saudi Arabia
Zhuping Xu
Citations per year, relative to Zhuping Xu Zhuping Xu (= 1×) peers Jingyi Wang

Countries citing papers authored by Zhuping Xu

Since Specialization
Citations

This map shows the geographic impact of Zhuping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuping Xu more than expected).

Fields of papers citing papers by Zhuping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuping Xu. The network helps show where Zhuping Xu may publish in the future.

Co-authorship network of co-authors of Zhuping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuping Xu. A scholar is included among the top collaborators of Zhuping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuping Xu. Zhuping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Pei & Zhuping Xu. (2025). The advancements in precision medicine for Leber congenital amaurosis: Breakthroughs from genetic diagnosis to therapy. Survey of Ophthalmology. 70(6). 1205–1219. 1 indexed citations
3.
Zhou, Lin, et al.. (2025). Genetic and clinical profile of high myopia patients with rhegmatogenous retinal detachment. Frontiers in Genetics. 16. 1485874–1485874.
4.
Zhang, Chun, Xiuxing Liu, Yidan Liu, et al.. (2024). Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis. Journal of Advanced Research. 72. 633–652. 2 indexed citations
5.
Zhang, Chun, et al.. (2023). Advances in the applications of mesenchymal stem cell-conditioned medium in ocular diseases. Experimental Eye Research. 233. 109560–109560. 8 indexed citations
6.
Jiang, Hui & Zhuping Xu. (2023). Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment. Drug Delivery. 30(1). 2204206–2204206. 33 indexed citations
7.
Zhang, Chun, et al.. (2023). Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma. BMC Ophthalmology. 23(1). 354–354. 6 indexed citations
8.
Zhang, Chun, Xiuxing Liu, Jing Xiao, et al.. (2023). γδ T cells in autoimmune uveitis pathogenesis: A promising therapeutic target. Biochemical Pharmacology. 213. 115629–115629. 3 indexed citations
9.
Liu, Xiuxing, Qi Jiang, Wen Ding, et al.. (2023). Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2/Pim1 axis. Journal of Neuroinflammation. 20(1). 144–144. 14 indexed citations
10.
Li, Yinggang, Zhonglan Chen, Lei Gu, et al.. (2022). Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opinion on Drug Delivery. 19(4). 337–354. 13 indexed citations
11.
Shi, Lingen, Xiaoxia Liu, Zhuping Xu, et al.. (2022). Prevalence of syphilis and chlamydia trachomatis infection among men who have sex with men in Jiangsu province, China: A cross-sectional survey. Frontiers in Public Health. 10. 1006254–1006254. 8 indexed citations
12.
Ren, Kebai, Yue Qiu, Zhuping Xu, et al.. (2022). A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis. Acta Biomaterialia. 145. 185–199. 23 indexed citations
13.
Yang, Guoyuan, Xi Huang, Bing-Jie Chen, & Zhuping Xu. (2021). Weill-Marchesani-like syndrome caused by an FBN1 mutation with low-penetrance. Chinese Medical Journal. 134(11). 1359–1361. 5 indexed citations
14.
Yang, Guoyuan, et al.. (2020). Endogenous Endophthalmitis Caused by <b><i>Klebsiella pneumoniae</i></b>: A Ten-Year Retrospective Study in Western China. Ophthalmic Research. 63(5). 507–516. 10 indexed citations
15.
Ning, Pingping, Xinglong Yang, Quanzhen Zhao, et al.. (2018). Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis. Neurological Sciences. 39(7). 1261–1266. 5 indexed citations
16.
Liu, Chunrong, Qin Li, Can Hou, et al.. (2018). Changes in Body Mass Index, Leptin, and Leptin Receptor Polymorphisms and Breast Cancer Risk. DNA and Cell Biology. 37(3). 182–188. 14 indexed citations
17.
Qiu, Yue, Qianwen Yu, Jiajing Tang, et al.. (2018). Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy. Pharmaceutical Research. 35(7). 130–130. 16 indexed citations
18.
Duan, Zhenyu, Hao Cai, Hu Zhang, et al.. (2018). PEGylated Multistimuli-Responsive Dendritic Prodrug-Based Nanoscale System for Enhanced Anticancer Activity. ACS Applied Materials & Interfaces. 10(42). 35770–35783. 43 indexed citations
19.
Chen, Jun, Bo Guo, Hong Lin, et al.. (2018). A novel NF1 frame-shift mutation c.703_704delTA in a Chinese pedigree with neurofibromatosis type 1. International Journal of Ophthalmology. 11(9). 1562–1565. 1 indexed citations
20.
Zeng, Liping, et al.. (2017). ipRGCs: possible causation accounts for the higher prevalence of sleep disorders in glaucoma patients. International Journal of Ophthalmology. 10(7). 1163–1167. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026